{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:11:35Z","timestamp":1792192295294,"version":"4.4.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T00:00:00Z","timestamp":1658966400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Richard \u00dcbelh\u00f6r Grant","award":["2019"],"award-info":[{"award-number":["2019"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Squamous cell carcinoma of the penis (PSC) is a rare disease with limited information on the molecular events leading to malignant transformation. In a third of PSC cases, presence of human papilloma virus (HPV) is found. The APOBEC3 family of proteins is known to play a significant role in defense against HPV infection, but their role in PSC is largely unknown. In this study, we aim to assess mRNA expression levels of APOBEC3 family members in HPV+\u2009and HPV\u2212 PSC to get insight into their association with clinicopathological features and to evaluate their prognostic impact. Expression levels of six <jats:italic>APOBEC3<\/jats:italic> family members in tissue from 50 patients with PSC were determined by RT-PCR and correlated with clinical and histopathological features. Lower expression of <jats:italic>APOBEC3A<\/jats:italic>, <jats:italic>APOBEC3B,<\/jats:italic> and <jats:italic>APOBEC3C<\/jats:italic> was observed in advanced PSC stages. Except for <jats:italic>APOBEC3D<\/jats:italic>, HPV+\u2009samples showed higher expression of <jats:italic>APOBEC3s<\/jats:italic> compared to HPV\u2212 samples. In univariate analyses, <jats:italic>APOBEC3A<\/jats:italic> and <jats:italic>APOBEC3C<\/jats:italic> expression tended to be associated with disease-free survival and <jats:italic>APOBEC3A<\/jats:italic> expression with overall survival; however, multivariable analyses failed to confirm these associations with outcome. More extensive external validation and functional laboratory studies are needed to evaluate further their role in PSC development and progression.<\/jats:p>","DOI":"10.1038\/s41598-022-17056-8","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T12:03:18Z","timestamp":1659009798000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Evaluation of APOBEC3 expression as prognostic marker in squamous cell carcinoma of the penis"],"prefix":"10.1038","volume":"12","author":[{"given":"Bettina","family":"Trimmel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Oszwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Diemand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris E.","family":"Ertl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Lemberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Bruchbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Brettner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Korn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Resch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Comperat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie R.","family":"Hassler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,28]]},"reference":[{"issue":"4","key":"17056_CR1","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s10552-008-9276-9","volume":"20","author":"DM Backes","year":"2009","unstructured":"Backes, D. M. et al. Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control 20(4), 449\u2013457 (2009).","journal-title":"Cancer Causes Control"},{"issue":"4","key":"17056_CR2","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1007\/s00345-011-0802-0","volume":"31","author":"A Chaux","year":"2013","unstructured":"Chaux, A. et al. Epidemiologic profile, sexual history, pathologic features, and human papillomavirus status of 103 patients with penile carcinoma. World J. Urol. 31(4), 861\u2013867 (2013).","journal-title":"World J. Urol."},{"key":"17056_CR3","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/1471-2407-12-30","volume":"12","author":"S Hartwig","year":"2012","unstructured":"Hartwig, S. et al. Estimation of the epidemiological burden of human papillomavirus-related cancers and non-malignant diseases in men in Europe: a review. BMC Cancer 12, 30 (2012).","journal-title":"BMC Cancer"},{"issue":"7","key":"17056_CR4","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1016\/j.tibs.2016.05.001","volume":"41","author":"JD Salter","year":"2016","unstructured":"Salter, J. D., Bennett, R. P. & Smith, H. C. The APOBEC protein family: united by structure divergent in function. Trends Biochem Sci 41(7), 578\u2013594 (2016).","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"17056_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1006\/geno.2002.6718","volume":"79","author":"A Jarmuz","year":"2002","unstructured":"Jarmuz, A. et al. An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22. Genomics 79(3), 285\u2013296 (2002).","journal-title":"Genomics"},{"issue":"6898","key":"17056_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nature00939","volume":"418","author":"AM Sheehy","year":"2002","unstructured":"Sheehy, A. M. et al. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418(6898), 646\u2013650 (2002).","journal-title":"Nature"},{"issue":"5873","key":"17056_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1126\/science.1153201","volume":"320","author":"JP Vartanian","year":"2008","unstructured":"Vartanian, J. P. et al. Evidence for editing of human papillomavirus DNA by APOBEC3 in benign and precancerous lesions. Science 320(5873), 230\u2013233 (2008).","journal-title":"Science"},{"issue":"9","key":"17056_CR8","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/ng.2702","volume":"45","author":"SA Roberts","year":"2013","unstructured":"Roberts, S. A. et al. An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers. Nat Genet 45(9), 970\u2013976 (2013).","journal-title":"Nat Genet"},{"issue":"3","key":"17056_CR9","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1159\/000479007","volume":"85","author":"M Heller","year":"2018","unstructured":"Heller, M. et al. APOBEC3A expression in penile squamous cell carcinoma. Pathobiology 85(3), 169\u2013178 (2018).","journal-title":"Pathobiology"},{"issue":"16","key":"17056_CR10","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1158\/0008-5472.CAN-15-3134","volume":"76","author":"A Feber","year":"2016","unstructured":"Feber, A. et al. CSN1 somatic mutations in penile squamous cell carcinoma. Cancer Res. 76(16), 4720\u20134727 (2016).","journal-title":"Cancer Res."},{"issue":"2","key":"17056_CR11","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1128\/JVI.03091-13","volume":"88","author":"Z Wang","year":"2014","unstructured":"Wang, Z. et al. APOBEC3 deaminases induce hypermutation in human papillomavirus 16 DNA upon beta interferon stimulation. J. Virol. 88(2), 1308\u20131317 (2014).","journal-title":"J. Virol."},{"issue":"1","key":"17056_CR12","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1038\/s41467-020-14730-1","volume":"11","author":"B Zhu","year":"2020","unstructured":"Zhu, B. et al. Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance. Nat. Commun. 11(1), 886 (2020).","journal-title":"Nat. Commun."},{"issue":"1","key":"17056_CR13","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1128\/JVI.02383-14","volume":"89","author":"CJ Warren","year":"2015","unstructured":"Warren, C. J. et al. APOBEC3A functions as a restriction factor of human papillomavirus. J. Virol. 89(1), 688\u2013702 (2015).","journal-title":"J. Virol."},{"issue":"9","key":"17056_CR14","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1158\/1078-0432.CCR-20-4004","volume":"27","author":"J Chahoud","year":"2021","unstructured":"Chahoud, J. et al. Whole-exome sequencing in penile squamous cell carcinoma uncovers novel prognostic categorization and drug targets similar to head and neck squamous cell carcinoma. Clin. Cancer Res. 27(9), 2560\u20132570 (2021).","journal-title":"Clin. Cancer Res."},{"issue":"7437","key":"17056_CR15","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/nature11881","volume":"494","author":"MB Burns","year":"2013","unstructured":"Burns, M. B. et al. APOBEC3B is an enzymatic source of mutation in breast cancer. Nature 494(7437), 366\u2013370 (2013).","journal-title":"Nature"},{"issue":"7","key":"17056_CR16","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1158\/2159-8290.CD-15-0344","volume":"5","author":"C Swanton","year":"2015","unstructured":"Swanton, C. et al. APOBEC enzymes: mutagenic fuel for cancer evolution and heterogeneity. Cancer Discov. 5(7), 704\u2013712 (2015).","journal-title":"Cancer Discov."},{"issue":"9","key":"17056_CR17","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1038\/ng.3378","volume":"47","author":"K Chan","year":"2015","unstructured":"Chan, K. et al. An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers. Nat. Genet. 47(9), 1067\u20131072 (2015).","journal-title":"Nat. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17056-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17056-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17056-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T04:35:33Z","timestamp":1669350933000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-17056-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,28]]},"references-count":17,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["17056"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-17056-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,28]]},"assertion":[{"value":"7 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SFS reports honoraria for lectures\/consulting boards for Astellas, Astra Zeneca, Bayer, BMS, Cepheid, Ferring, Ipsen, Janssen, Lilly, MSD, Olympus, Pfizer, Pierre Fabre, Richard Wolf Roche, Sanochemia, Sanofi, Takeda, Urogen; patents: method to determine prognosis after therapy for prostate cancer granted 2002-09-06, methods to determine prognosis after therapy for bladder cancer granted 2003-06-19, prognostic methods for patients with prostatic disease granted 2004-08-05 and soluble Fas urinary marker for the detection of bladder transitional cell carcinoma granted 2010-07-20. The other authors have no competing interests to declare that are relevant to the content of this article.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12911"}}